Form 4: Metagenomi Executive Sells Shares to Cover Tax Obligations on RSU Vesting

Matthew Wein, Senior Vice President at Metagenomi, Inc., sold 199 shares of common stock for $1.75 per share to cover tax withholding obligations related to vested restricted stock units.

Summary

• Matthew Wein, Senior Vice President, Head of Legal, Compliance Officer, and Corporate Secretary of Metagenomi, Inc. (MGX), reported a transaction on June 6, 2025.
• The transaction involved the sale of 199 shares of Metagenomi common stock at a price of $1.75 per share.
• This sale was not a volitional trade but an automatic sale to satisfy tax withholding obligations upon the vesting of restricted stock units (RSUs).
• The RSUs were originally granted to Mr. Wein on April 1, 2024.
• Following this transaction, Mr. Wein beneficially owns 16,693 shares of Metagenomi common stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The transaction is a routine, non-volitional sale for tax purposes related to RSU vesting, which is a standard part of executive compensation and does not indicate a positive or negative discretionary action by the insider.

Positives

• The transaction indicates the vesting of restricted stock units (RSUs) granted to a key executive, which can be seen as a positive sign of employee retention and long-term incentives.
• The sale was non-volitional, solely for tax withholding purposes, suggesting it does not reflect a negative outlook on the company by the executive.

Negatives

• No specific negatives are indicated by this routine, non-volitional transaction.

Future Outlook

This Form 4 filing does not provide any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• "These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person."

Industry Context

Form 4 filings are routine disclosures required by the SEC for insiders (officers, directors, and 10% owners) to report changes in their beneficial ownership of company securities. This specific filing details a common practice where shares are sold to cover tax liabilities arising from the vesting of equity awards, which is a standard component of executive compensation across various industries.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a small, non-volitional sale for tax purposes, not indicative of a change in executive confidence.
• Employees: Reinforces the standard practice of equity compensation and its tax implications for executives.

Key Dates

Keywords

Metagenomi, MGX, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, RSU Vesting, Executive Compensation